| Trial ID: | L3024 |
| Source ID: | NCT01324739
|
| Associated Drug: |
Human Bnp-32
|
| Title: |
B-type Natriuretic Peptide and Glucose Metabolism
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus|Cardiomyopathy
|
| Interventions: |
DRUG: human BNP-32
|
| Outcome Measures: |
Primary: glucose, 0 to 180 minutes | Secondary: insulin, c-peptide, 0 to 180 minutes
|
| Sponsor/Collaborators: |
Sponsor: Medical University of Vienna
|
| Gender: |
MALE
|
| Age: |
ADULT
|
| Phases: |
|
| Enrollment: |
10
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2010-05
|
| Completion Date: |
2010-10
|
| Results First Posted: |
|
| Last Update Posted: |
2011-03-29
|
| Locations: |
Medical University of Vienna, Vienna, 1090, Austria
|
| URL: |
https://clinicaltrials.gov/show/NCT01324739
|
